Pfizer

Pfizer product PR still up for grabs
Pfizer product PR still up for grabs
Medical Marketing and Media
Pfizer
public relations
Flag link:
FDA Shows Confidence in Pfizer’s Maternal RSV Shot Ahead of Panel
FDA Shows Confidence in Pfizer’s Maternal RSV Shot Ahead of Panel
BioSpace
Pfizer
FDA
RSV
vaccines
Abrysvo
Flag link:
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Flag link:
Heightened US antitrust fears rattle biopharma
Heightened US antitrust fears rattle biopharma
EP Vantage
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Flag link:
Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine
Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine
CNBC
Google
Google Cloud
artificial intelligence
drug discovery
precision medicine
Pfizer
Colossal Biosciences
Cerevel Therapeutics
Flag link:
Pfizer RSV vaccine seen as effective against severe disease, FDA documents say
Pfizer RSV vaccine seen as effective against severe disease, FDA documents say
Stat
Pfizer
RSV
vaccines
infants
pregnancy
FDA
Flag link:
Pfizer CEO Bourla slams Medicare IRA measure as 'negotiation with a gun to your head'
Pfizer CEO Bourla slams Medicare IRA measure as 'negotiation with a gun to your head'
Fierce Pharma
Pfizer
Albert Bourla
drug pricing
Pharma CEOs
Inflation Reduction Act
Flag link:
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Fierce Pharma
Pfizer
Seagen
M&A
antitrust
DOJ
FTC
Flag link:
The waxing and waning of the speedy approval
The waxing and waning of the speedy approval
EP Vantage
FDA
drug approvals
accelerated approvals
AbbVie
AstraZeneca
Bayer
Bristol Myers Squibb
JNJ
Merck
Merck KGaA
Novartis
Pfizer
Flag link:
GSK tees up Pfizer fight with pivotal meningitis vaccine data
GSK tees up Pfizer fight with pivotal meningitis vaccine data
Fierce Biotech
GSK
Pfizer
vaccines
meningitis
Flag link:
2023’s biggest launches: the story so far
2023’s biggest launches: the story so far
EP Vantage
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
Flag link:
A blockbuster year could be building
A blockbuster year could be building
EP Vantage
AbbVie
Amgen
AstraZeneca
Bristol Myers Squibb
Daiichi Sankyo
Eli Lilly
Gilead Sciences
Horizon Therapeutics
Merck
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
Flag link:
AstraZeneca, Pfizer Top 2023 Pharma List for Invention and Innovation
AstraZeneca, Pfizer Top 2023 Pharma List for Invention and Innovation
BioSpace
reputation
AstraZeneca
Pfizer
innovation
IDEA Pharma
Flag link:
Valneva, Pfizer push back timeline for Lyme disease vaccine
Valneva, Pfizer push back timeline for Lyme disease vaccine
BioPharma Dive
Pfizer
Valneva
vaccines
Lyme disease
Flag link:
Poland takes its COVID-19 vaccine fight to Pfizer's shareholders, urging the company to be a good corporate citizen
Poland takes its COVID-19 vaccine fight to Pfizer's shareholders, urging the company to be a good corporate citizen
Fierce Pharma
Poland
Pfizer
BioNTech
vaccines
COVID-19
Flag link:
The race for gold: Closing in on the first RSV vaccine
The race for gold: Closing in on the first RSV vaccine
Pharmaphorum
vaccines
RSV
GSK
Pfizer
Moderna Therapeutics
Flag link:
Pfizer kicks newly acquired meds out of Arena as part of midstage cleaning
Pfizer kicks newly acquired meds out of Arena as part of midstage cleaning
Fierce Biotech
Pfizer
Arena Pharmaceuticals
etrasimod
M&A
Flag link:
Pfizer reports strong Q1 earnings, including $18.3B in revenues
Pfizer reports strong Q1 earnings, including $18.3B in revenues
Medical Marketing and Media
Pfizer
earnings
COVID-19
vaccines
Paxlovid
Flag link:
Pfizer, Astellas' Xtandi combo cuts risk of death by 58% in prostate cancer patients
Pfizer, Astellas' Xtandi combo cuts risk of death by 58% in prostate cancer patients
Seeking Alpha
Pfizer
Astellas
Xtandi
prostate cancer
clinical trials
Flag link:
Pfizer wins FDA nod for Prevnar 20 pneumonia vaccine in children
Pfizer wins FDA nod for Prevnar 20 pneumonia vaccine in children
Seeking Alpha
Pfizer
vaccines
FDA
Prevnar 20
pneumococcal disease
pediatric
Flag link:

Pages